Search
for
Sort by
Research 151–180 of 1000+
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Under Development JAK Inhibitors for Dermatologic Diseases
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- S100A6 Protein—Expression and Function in Norm and Pathology
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Alopecia areata following COVID-19 vaccine: a systematic review
- Mechanisms of autophagy and their implications in dermatological disorders
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- Recent advances in exosomal non‐coding RNA‐based therapeutic approaches for photoaging
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Pathophysiology of Insulin Resistance and Related Skin Diseases ( Review Article)
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol